| Effectiveness of face mask or respirator use in indoor public settings for prevention of SARS-CoV-2 infection—California, February–December 2021 KL Andrejko, JM Pry, JF Myers, N Fukui, JL DeGuzman, J Openshaw, ... Morbidity and Mortality Weekly Report 71 (6), 212, 2022 | 179 | 2022 |
| Prevention of COVID-19 by mRNA-based vaccines within the general population of California KL Andrejko, JM Pry, JF Myers, N Jewell, J Openshaw, Watt, S Jain, ... Clinical Infectious Diseases, 2021 | 55* | 2021 |
| California COVID-19 Case-Control Study Team. Effectiveness of face mask or respirator use in indoor public settings for prevention of SARS-CoV-2 infection—California, February … KL Andrejko, JM Pry, JF Myers, N Fukui, JL DeGuzman, J Openshaw, ... MMWR Morb Mortal Wkly Rep 71 (6), 212-216, 2022 | 35 | 2022 |
| Predictors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Following High-Risk Exposure K Andrejko, JM Pry, JF Myers, J Openshaw, J Watt, N Fukui, ... Clinical Infectious Diseases, 2021 | 30 | 2021 |
| Real-world uptake of COVID-19 vaccination among individuals expressing vaccine hesitancy: a registry-linkage study KL Andrejko, JF Myers, N Fukui, L Nelson, R Zhao, J Openshaw, JP Watt, ... medRxiv preprint, 2022 | 11 | 2022 |
| Waning of two-dose BNT162b2 and mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection is robust to depletion-of-susceptibles bias KL Andrejko, JM Pry, JF Myers, M Mehrotra, K Lamba, E Lim, N Fukui, ... medRxiv, 2022 | 9* | 2022 |
